Samjin Pharmaceuticals Co., Ltd. (005500.KS)
KRW 18280.0
(-0.33%)
KRW 18280.0
(-0.33%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1460.00 KRW | -15.52% |
| 2022 | 1727.82 KRW | -25.16% |
| 2021 | 2308.75 KRW | 1.88% |
| 2020 | 2266.09 KRW | 147.1% |
| 2019 | 917.07 KRW | -55.81% |
| 2018 | 2075.29 KRW | -28.22% |
| 2017 | 2891.00 KRW | 19.31% |
| 2016 | 2423.00 KRW | 11.56% |
| 2015 | 2172.00 KRW | 30.53% |
| 2014 | 1664.00 KRW | 165.39% |
| 2013 | 627.00 KRW | -23.26% |
| 2012 | 817.00 KRW | 50.74% |
| 2011 | 542.00 KRW | -33.66% |
| 2010 | 817.00 KRW | 48.85% |
| 2009 | 548.87 KRW | 4.53% |
| 2008 | 525.07 KRW | 5.68% |
| 2007 | 496.85 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 242.58 KRW | -57.99% |
| 2024 Q2 | 1947.17 KRW | 702.69% |
| 2023 Q4 | 577.37 KRW | 135.11% |
| 2023 FY | - KRW | -15.52% |
| 2023 Q1 | 662.46 KRW | -10.54% |
| 2023 Q2 | 62.40 KRW | -90.58% |
| 2023 Q3 | 245.57 KRW | 293.54% |
| 2022 FY | - KRW | -25.16% |
| 2022 Q3 | 337.34 KRW | -0.88% |
| 2022 Q4 | 740.55 KRW | 119.53% |
| 2022 Q1 | 295.00 KRW | 249.91% |
| 2022 Q2 | 340.34 KRW | 15.37% |
| 2021 Q2 | 668.00 KRW | 20.8% |
| 2021 Q4 | -196.79 KRW | -115.3% |
| 2021 Q3 | 1286.00 KRW | 92.51% |
| 2021 FY | - KRW | 1.88% |
| 2021 Q1 | 553.00 KRW | 15.21% |
| 2020 FY | - KRW | 147.1% |
| 2020 Q1 | 690.00 KRW | 258.83% |
| 2020 Q3 | 443.00 KRW | -32.16% |
| 2020 Q4 | 480.01 KRW | 8.35% |
| 2020 Q2 | 653.00 KRW | -5.36% |
| 2019 Q1 | 932.00 KRW | 234.92% |
| 2019 Q2 | -906.00 KRW | -197.21% |
| 2019 Q4 | 192.29 KRW | -74.26% |
| 2019 FY | - KRW | -55.81% |
| 2019 Q3 | 747.00 KRW | 182.45% |
| 2018 Q4 | -690.76 KRW | -174.04% |
| 2018 FY | - KRW | -28.22% |
| 2018 Q3 | 933.00 KRW | -2.41% |
| 2018 Q2 | 956.00 KRW | 9.01% |
| 2018 Q1 | 877.00 KRW | 55.3% |
| 2017 Q1 | 690.00 KRW | 83.65% |
| 2017 Q2 | 781.00 KRW | 13.19% |
| 2017 Q3 | 853.00 KRW | 9.22% |
| 2017 FY | - KRW | 19.31% |
| 2017 Q4 | 564.73 KRW | -33.79% |
| 2016 Q4 | 375.71 KRW | -48.67% |
| 2016 Q1 | 647.00 KRW | 34.42% |
| 2016 FY | - KRW | 11.56% |
| 2016 Q2 | 668.00 KRW | 3.25% |
| 2016 Q3 | 732.00 KRW | 9.58% |
| 2015 Q4 | 481.33 KRW | -17.86% |
| 2015 Q2 | 575.00 KRW | 8.7% |
| 2015 FY | - KRW | 30.53% |
| 2015 Q3 | 586.00 KRW | 1.91% |
| 2015 Q1 | 529.00 KRW | 160.67% |
| 2014 Q2 | 475.00 KRW | -8.48% |
| 2014 Q1 | 519.00 KRW | 28.67% |
| 2014 FY | - KRW | 165.39% |
| 2014 Q4 | 202.94 KRW | -55.98% |
| 2014 Q3 | 461.00 KRW | -2.95% |
| 2013 Q3 | 442.00 KRW | 163.14% |
| 2013 FY | - KRW | -23.26% |
| 2013 Q2 | -700.00 KRW | -245.83% |
| 2013 Q1 | 480.00 KRW | 127.15% |
| 2013 Q4 | 403.36 KRW | -8.74% |
| 2012 Q1 | 155.00 KRW | 377.43% |
| 2012 Q2 | 183.00 KRW | 18.06% |
| 2012 Q3 | 268.00 KRW | 46.45% |
| 2012 Q4 | 211.31 KRW | -21.15% |
| 2012 FY | - KRW | 50.74% |
| 2011 Q4 | -55.87 KRW | -120.77% |
| 2011 Q1 | 317.00 KRW | 161.64% |
| 2011 Q2 | 12.00 KRW | -96.21% |
| 2011 FY | - KRW | -33.66% |
| 2011 Q3 | 269.00 KRW | 2141.67% |
| 2010 FY | - KRW | 48.85% |
| 2010 Q2 | 152.25 KRW | -40.3% |
| 2010 Q3 | 263.77 KRW | 73.25% |
| 2010 Q1 | 255.04 KRW | 2173.08% |
| 2010 Q4 | 121.16 KRW | -54.07% |
| 2009 Q3 | 128.92 KRW | -15.95% |
| 2009 Q4 | 11.22 KRW | -91.3% |
| 2009 Q1 | 239.95 KRW | 685.69% |
| 2009 FY | - KRW | 4.53% |
| 2009 Q2 | 153.38 KRW | -36.08% |
| 2008 Q3 | 89.47 KRW | -41.32% |
| 2008 Q4 | 30.54 KRW | -65.87% |
| 2008 FY | - KRW | 5.68% |
| 2008 Q1 | 240.85 KRW | 1376.7% |
| 2008 Q2 | 152.47 KRW | -36.7% |
| 2007 Q1 | 232.40 KRW | 0.0% |
| 2007 Q3 | 85.66 KRW | -43.71% |
| 2007 Q2 | 152.18 KRW | -34.52% |
| 2007 FY | - KRW | 0.0% |
| 2007 Q4 | 16.31 KRW | -80.96% |